{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:17:06Z","timestamp":1788333426453,"version":"build-2803163510"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Shanghai Hospital Development Center","award":["SHDC2020CR4050"],"award-info":[{"award-number":["SHDC2020CR4050"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,17]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, characterized by favorable prognosis and low incidence of distant metastasis. However, brain metastasis from PTC is rare, and its development years after the initial diagnosis is even more uncommon. Given the potential clinical implications of late metastasis, there is a need to reconsider follow-up strategies for high-risk PTC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 54-year-old woman with a history of PTC diagnosed 8 years earlier presented with progressive headaches and mild left-sided hemiparesis. She had previously undergone multiple surgeries and radioiodine therapy after the initial diagnosis and had a history of childhood neck irradiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Imaging revealed a brain mass, which was confirmed as isolated brain metastasis from PTC following biopsy after surgical resection. Despite persistently undetectable serum thyroglobulin (Tg) levels and no lymph node metastasis at the time of primary surgery, this patient developed isolated brain metastasis 8 years after initial treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient underwent craniotomy to remove the metastatic brain lesion. No adjuvant radiotherapy was given postoperatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient recovered well after surgery, with mild left-sided hemiparesis (4\/5 muscle strength). At the most recent follow-up, no additional distant metastases were detected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>This case highlights the importance of extending the follow-up period for high-risk PTC patients, including those with prior neck irradiation or aggressive tumor features. Late metastasis can occur even in patients with initially favorable prognoses and normal biochemical markers. Imaging-based surveillance is necessary to detect late metastasis early. The findings support extended follow-up strategies to enable timely intervention and improve outcomes in high-risk patients with PTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049774","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T21:03:19Z","timestamp":1784322199000},"page":"e49774","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["How long should we follow up patients with papillary thyroid carcinoma?: A case report describing brain metastasis after 8 years"],"prefix":"10.1097","volume":"105","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[{"name":"Department of General Practice, Xie Tu Community Health Service Center Xu Hui District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-8257","authenticated-orcid":false,"given":"Yidong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260902","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1586\/14737140.9.3.317","article-title":"Contemporary management of papillary carcinoma of the thyroid gland.","volume":"9","author":"Rosenbaum","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"R2-20260902","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.wneu.2019.06.164","article-title":"Late-onset metastasis of intracranial papillary thyroid carcinoma.","volume":"130","author":"Avci","year":"2019","journal-title":"World Neurosurg"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.5858\/2006-130-1057-PTCAO","article-title":"Papillary thyroid carcinoma: an overview.","volume":"130","author":"Al-Brahim","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R4-20260902","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.3390\/ijms26115173","article-title":"Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies.","volume":"26","author":"Forma","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","article-title":"Papillary thyroid cancer-aggressive variants and impact on management: a narrative review.","volume":"37","author":"Coca-Pelaz","year":"2020","journal-title":"Adv Ther"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","article-title":"High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks.","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discovery"},{"key":"R7-20260902","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/cancers13071625","article-title":"Site-specific metastasis and survival in papillary thyroid cancer: the importance of brain and multi-organ disease.","volume":"13","author":"Toraih","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1245\/s10434-009-0571-9","article-title":"High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.","volume":"16","author":"Hartl","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"R9-20260902","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3892\/mco.2013.139","article-title":"Brain metastasis from papillary thyroid carcinomas.","volume":"1","author":"Tsuda","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"107639","DOI":"10.1016\/j.clineuro.2023.107639","article-title":"Brain metastases of papillary thyroid carcinoma origin are derived from aggressive histologic variants and demonstrate similar adverse morphology in the metastatic lesion.","volume":"227","author":"Gubbiotti","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"R11-20260902","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1186\/s12885-025-14709-5","article-title":"Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence.","volume":"25","author":"Jeong","year":"2025","journal-title":"BMC Cancer"},{"key":"R12-20260902","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cen.13965","article-title":"Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: a systematic review and meta-analysis.","volume":"91","author":"Huang","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00268-018-4479-z","article-title":"Overall survival of papillary thyroid carcinoma patients: a single-institution long-term follow-up of 5897 patients.","volume":"42","author":"Ito","year":"2018","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"R14-20260902","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2010.129","article-title":"Papillary thyroid carcinoma: an update.","volume":"24","author":"LiVolsi","year":"2011","journal-title":"Mod Pathol"},{"key":"R15-20260902","doi-asserted-by":"crossref","first-page":"973497","DOI":"10.1155\/2012\/973497","article-title":"Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.","volume":"2012","author":"Ito","year":"2012","journal-title":"J Thyroid Res"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5455\/medarh.2018.72.108-111","article-title":"Lymph node metastases papillary thyroid carcinoma and their importance in recurrence of disease.","volume":"72","author":"Maksimovic","year":"2018","journal-title":"Med Arch"},{"key":"R17-20260902","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer.","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/HP.0b013e3182082f12","article-title":"Radiation-induced genomic instability.","volume":"100","author":"Morgan","year":"2011","journal-title":"Health Phys"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"e0173354","DOI":"10.1371\/journal.pone.0173354","article-title":"Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis.","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"R21-20260902","doi-asserted-by":"crossref","first-page":"S1009","DOI":"10.4103\/jcrt.jcrt_1216_22","article-title":"Is lifelong follow-up necessary for low-risk papillary thyroid carcinoma? Case series and a review of the literature.","volume":"19","author":"Bah\u00e7ecio\u011flu","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jso.26090","article-title":"Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.","volume":"122","author":"Kim","year":"2020","journal-title":"J Surg Oncol"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"9542","DOI":"10.1038\/s41598-025-92295-z","article-title":"Predictive risk-scoring model for lateral lymph node metastasis in papillary thyroid carcinoma.","volume":"15","author":"Guo","year":"2025","journal-title":"Sci Rep"},{"key":"R24-20260902","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.acra.2022.04.007","article-title":"Performance of machine learning methods based on multi-sequence textural parameters using magnetic resonance imaging and clinical information to differentiate malignant and benign soft tissue tumors.","volume":"30","author":"Nakagawa","year":"2023","journal-title":"Acad Radiol"},{"key":"R25-20260902","doi-asserted-by":"crossref","first-page":"100441","DOI":"10.1016\/j.mtbio.2022.100441","article-title":"Optical diagnostic imaging and therapy for thyroid cancer.","volume":"17","author":"Shao","year":"2022","journal-title":"Mater Today Bio"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13044-023-00146-8","article-title":"Screening and treatment of brain metastasis from papillary thyroid carcinoma: a case series.","volume":"16","author":"Ha","year":"2023","journal-title":"Thyroid Res"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1308\/rcsann.2020.0041","article-title":"Papillary thyroid microcarcinoma presenting as a metastasis to the brain.","volume":"102","author":"Shawky","year":"2020","journal-title":"Ann R Coll Surg Engl"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-0716-2505-7_8","article-title":"Concepts of pathological staging and prognosis in papillary thyroid carcinoma.","volume":"2534","author":"Lam","year":"2022","journal-title":"Methods Mol Biol"},{"key":"R29-20260902","first-page":"23","article-title":"Subcentimetric papillary thyroid carcinoma with extensive lymph node and brain metastasis: case report and review of literature.","volume":"2023","author":"Amado","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"R30-20260902","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1385\/ENDO:25:2:187","article-title":"Intrathyroideal papillary thyroid carcinoma presenting with a solitary brain metastasis.","volume":"25","author":"Erem","year":"2004","journal-title":"Endocrine"},{"key":"R31-20260902","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1089\/thy.2024.0240","article-title":"Brain metastases in differentiated thyroid cancer: clinical presentation, diagnosis, and management.","volume":"34","author":"Prinzi","year":"2024","journal-title":"Thyroid"},{"key":"R32-20260902","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/s12885-023-11307-1","article-title":"Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Cancer"},{"key":"R33-20260902","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s42000-021-00283-5","article-title":"Efficacy and safety of radiofrequency ablation in the treatment of low-risk papillary thyroid carcinoma: a review.","volume":"20","author":"Ntelis","year":"2021","journal-title":"Hormones (Athens)"},{"key":"R34-20260902","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/jjco\/hys007","article-title":"Re-irradiation for metastatic brain tumors with whole-brain radiotherapy.","volume":"42","author":"Akiba","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"R35-20260902","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ncl.2021.11.002","article-title":"Surgery, stereotactic radiosurgery, and systemic therapy in the management of operable brain metastasis.","volume":"40","author":"Kotecha","year":"2022","journal-title":"Neurol Clin"},{"key":"R36-20260902","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s11912-025-01729-4","article-title":"Progress in drug-targeted therapy for papillary thyroid carcinoma.","volume":"27","author":"Wang","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"R37-20260902","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4132\/jptm.2024.07.29","article-title":"TERT mutations and aggressive histopathologic characteristics of radioiodine-refractory papillary thyroid cancer.","volume":"58","author":"Pyo","year":"2024","journal-title":"J Pathol Transl Med"},{"key":"R38-20260902","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1507\/endocrj.EJ20-0063","article-title":"BRAF and TERT promoter mutations: clinical application in thyroid cancer.","volume":"67","author":"Chung","year":"2020","journal-title":"Endocr J"},{"key":"R39-20260902","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1089\/thy.2013.0235","article-title":"Concomitant BRAF(V600E) mutation and RET\/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.","volume":"24","author":"Guerra","year":"2014","journal-title":"Thyroid"},{"key":"R40-20260902","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fendo.2012.00054","article-title":"RET\/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma.","volume":"3","author":"Romei","year":"2012","journal-title":"Front Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049774","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:01:34Z","timestamp":1788332494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":40,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049774","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2025-09-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}